Five Yale researchers awarded grants to study women’s reproductive cancers
Five researchers from the Yale School of Medicine have received grants from Discovery to Cure, a program at the Department of Obstetrics, Gynecology, and Reproductive Sciences that advances the prevention, early detection, and treatment of women’s reproductive cancers such as ovarian, uterine, cervical, vaginal, and vulvar cancers.
Angelique W. Levi, MD, in Honor of Cervical Health Awareness Month
In recognition of Cervical Health Awareness Month, Dr. Angelique Levi, Associate Professor of Pathology; Vice Chair of Pathology; and Director, Yale Pathology Outreach Program, shares the importance of prevention and screening for cervical cancer, and how she collaborates with others at Yale Cancer Center and Smilow Cancer Hospital.
Examining Genomics in the Treatment of Cervical Cancer
Could targeted therapy play a larger role in the treatment of cervical cancer in the near future? Researchers from Yale Cancer Center believe they are one step closer to finding out, according to new study findings published in the Proceedings of the National Academy of Sciences.Source: Cure Today
HEALTH NOTES: Black and Hispanic Cancer Patients Are Underrepresented in Clinical Trials
A new study has shown that clinical trials for new cancer medications rarely analyze data on safety and effectiveness by race and that black and Hispanic patients are consistently underrepresented among participants.